QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 electrocore-announces-its-gammacore-sapphire-non-invasive-vagus-nerve-stimulation-device-has-been-included-in-long-term-reimbursement-policy-by-belgiums-national-institute-for-health-and-disability-insurance

electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCor...

 electrocore-q2-eps-044-misses-031-estimate-sales-7381m-beat-7219m-estimate

electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.31)...

 electrocore-q1-eps-047-misses-035-estimate-sales-672m-miss-768m-estimate

electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.35)...

 hc-wainwright--co-reiterates-buy-on-electrocore-maintains-25-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates electroCore (NASDAQ:ECOR) with a Buy and maintains $25 pri...

 electrocore-announces-issuance-of-2-us-patents-entitled-devices-and-methods-for-vagal-nerve-stimulation-devices-and-methods-for-remote-therapy-and-patient-monitoring

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it has re...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION